Cost-effectiveness of HMG-COA reductase inhibition in primary prevention of CHD: New evidence comparing all available agents

被引：0

|

作者：

Huse, DM

Russell, MW

Miller, JD

Kraemer, DF

Hartz, SC

机构：

[1] MED RES INT,BURLINGTON,MA

[2] WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES,ANN ARBOR,MI 48105

来源：

AMERICAN JOURNAL OF MANAGED CARE | 1997年 / 3卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

引用

收藏

页码：LC21 / LC21

页数：1

相关论文

共 44 条

[1] COST-EFFECTIVENESS OF HMG-COA REDUCTASE INHIBITION FOR PRIMARY AND SECONDARY PREVENTION OF CORONARY HEART-DISEASE
GOLDMAN, L
WEINSTEIN, MC
GOLDMAN, PA
WILLIAMS, LW
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (09): : 1145 - 1151
[2] Comparative cost-effectiveness of HMG-COA reductase inhibitors in secondary prevention of myocardial infarction
Elliott, WJ
Weir, DR
[J]. AMERICAN JOURNAL OF MANAGED CARE, 1997, 3 (10): : LC15 - LC15
[3] Comparative cost-effectiveness of HMG-CoA reductase inhibitors in secondary prevention of acute myocardial infarction
Elliott, WJ
Weir, DR
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (17) : 1726 - 1732
[4] Critical evaluation of a cost-effectiveness analysis of four HMG-CoA reductase inhibitors
Cox, ER
Griffis, DL
[J]. FORMULARY, 1999, 34 (12) : 1041 - +
[5] Cost effectiveness analysis of HMG-COA reductase inhibitors in a medicaid population
MacLean, EA
Moffitt, CM
[J]. VALUE IN HEALTH, 2003, 6 (03) : 319 - 320
[6] COST-EFFECTIVENESS ANALYSIS OF LIPID-MODIFYING THERAPY IN CANADA - COMPARISON OF HMG-COA REDUCTASE INHIBITORS IN THE PRIMARY PREVENTION OF CORONARY HEART-DISEASE
MARTENS, LL
GUIBERT, R
[J]. CLINICAL THERAPEUTICS, 1994, 16 (06) : 1052 - 1062
[7] COST-EFFECTIVENESS ANALYSIS OF LIPID-MODIFYING THERAPY IN CANADA - COMPARISON OF HMG-COA REDUCTASE INHIBITORS IN THE PRIMARY PREVENTION OF CORONARY HEART-DISEASE
JOLAIN, B
PETTITT, D
[J]. CLINICAL THERAPEUTICS, 1995, 17 (03) : 572 - 575
[8] Explaining statin inhibition effectiveness of HMG-CoA reductase by quantum biochemistry computations
da Costa, Roner F.
Freire, Valder N.
Bezerra, Eveline M.
Cavada, Benildo S.
Caetano, Ewerton W. S.
de Lima Filho, Jose L.
Albuquerque, Eudenilson L.
[J]. PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2012, 14 (04) : 1389 - 1398
[9] COST-EFFECTIVENESS ANALYSIS OF LIPID-MODIFYING THERAPY IN CANADA - COMPARISON OF HMG-COA REDUCTASE INHIBITORS IN THE PRIMARY PREVENTION OF CORONARY HEART-DISEASE - REPLY
GUIBERT, R
[J]. CLINICAL THERAPEUTICS, 1995, 17 (03) : 575 - 580
[10] HMG-COA REDUCTASE INHIBITION - THE START OF A NEW AGE IN THE TREATMENT OF HYPERCHOLESTEROLEMIA
MEINDERS, AE
[J]. NETHERLANDS JOURNAL OF MEDICINE, 1988, 32 (5-6): : 213 - 216

← 1 2 3 4 5 →